# Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

> **NCT04469842** · EARLY_PHASE1 · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 48 (estimated)

## Conditions studied

- Lung Transplant; Complications

## Interventions

- **DRUG:** Tacrolimus Extended Release Oral Tablet [Envarsus]
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate Mofetil Hydrochloride
- **DRUG:** Prednisone
- **DRUG:** Azathioprine

## Key facts

- **NCT ID:** NCT04469842
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04469842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04469842, "Early Use of Long-acting Tacrolimus in Lung Transplant Recipients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04469842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*